Paulson initiated a Shire Plc position in the third quarter of 2012.

FORBES: John Paulson's 4 Stocks Trading at 52-Week Lows

The family will need to make the trip three times for the study, which is sponsored by biopharmaceutical company Shire PLC.

WSJ: Families Push for New Ways to Research Rare Diseases

Other major players include Alexion Pharmaceuticals, BioMarin, and Shire PLC.

FORBES: Pfizer Enters Market For Super-Expensive, Ultra-Rare Disease Drugs -- With A Price Cut